Just one US state legalizing cannabis can cost the pharmaceutical sector nearly $10 billion, according to a new, first-of-its-kind study from researchers at California Polytechnic State University and the University of New Mexico.
Researchers used survey data from more than 3,400 adult twins – 111 of which were identical – to study recent trends in cannabis use and the factors affecting it.
The labs allegedly reported false information on their certificates of analysis.
Over 37,000 cannabis beverages have been recalled in Canada over fears that “pinhole leaks” could form in the aluminum cans, which could lead to leaks and a loss of carbonation.
California’s cannabis regulator has seized over a billion dollars’ worth of illicit cannabis over the last thirteen months.
The affected products were sold under the YHN brand from November 12, 2021, until July 6, 2022, at two licensed dispensaries in eastern Oregon.
The Maine-based company is the seventh to receive such a license “for the bulk manufacture of cannabis to supply marijuana, cannabis extracts and THC to researchers.”
A new preprint study from food chemists and public health experts at the Chemical and Veterinary Investigation Office Karlsruhe, Germany, provides a deeper look into the European Food Safety Authority's decision to halt novel food applications for CBD products.
The finding that cannabis legalization could help reduce synthetic cannabinoid exposures through offering a safer alternative is an important new perspective on harm reduction